SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-029776
Filing Date
2020-10-29
Accepted
2020-10-29 20:45:19
Documents
3
Period of Report
2020-10-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 11756
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4406
3 EX-24.2 DOCUMENT attachment2.htm EX-24.2 4536
  Complete submission text file 0000899243-20-029776.txt   22689
Mailing Address C/O IDENIX PHARMACEUTICALS, INC. 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address
Sommadossi Jean-Pierre (Reporting) CIK: 0001296995 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39661 | Film No.: 201274371

Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Issuer) CIK: 0001593899 (see all company filings)

IRS No.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ATEA PHARMACEUTICALS, INC. 125 SUMMER STREET BOSTON MA 02110
Business Address C/O ATEA PHARMACEUTICALS, INC. 125 SUMMER STREET BOSTON MA 02110 (857) 284-8891
JPM Partners LLC (Reporting) CIK: 0001830495 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39661 | Film No.: 201274372